Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Cancer Institute (NCI)
SystImmune Inc.
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
Tomsk National Research Medical Center of the Russian Academy of Sciences
ViroMissile, Inc.
Replimune Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
Nanjing Sanhome Pharmaceutical, Co., Ltd.
SystImmune Inc.
Eli Lilly and Company
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Shanghai Juncell Therapeutics
The First Affiliated Hospital of Xinxiang Medical College
AstraZeneca
Sanofi
Circle Pharma
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
Novita Pharmaceuticals, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Thomas Jefferson University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Black Diamond Therapeutics, Inc.
Williams Cancer Foundation
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Compugen Ltd
Vincerx Pharma, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Second Affiliated Hospital of Guangzhou Medical University
Celldex Therapeutics
Lebanese University
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd